| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| loperamide | voltage-dependent p/q-type calcium channel subunit alpha-1a | small molecule | NA | drugbank | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| loperamide | voltage-dependent p/q-type calcium channel subunit alpha-1a | small molecule | NA | drugbank | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | approved | inhibitor |
| loperamide | calmodulin | small molecule | NA | drugbank | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| loperamide | calmodulin | small molecule | NA | drugbank | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | approved | inhibitor |
| loperamide | nuclear receptor subfamily 1 group i member 3 | small molecule | NA | drugbank | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| loperamide | nuclear receptor subfamily 1 group i member 3 | small molecule | NA | drugbank | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | approved | unknown |
| loperamide | delta-type opioid receptor | small molecule | NA | drugbank , DGIDB | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.39 | approved | agonist |
| loperamide | opioid receptor delta | NA | Successful target | TTD , DGIDB | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.39 | approved | unknown |
| loperamide | delta-type opioid receptor | small molecule | NA | drugbank , DGIDB | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.39 | approved | agonist |
| loperamide | opioid receptor delta | NA | Successful target | TTD , DGIDB | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.39 | approved | unknown |
| loperamide | kappa-type opioid receptor | small molecule | NA | drugbank | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | agonist |
| loperamide | kappa-type opioid receptor | small molecule | NA | drugbank | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | approved | agonist |
| loperamide | mu-type opioid receptor | small molecule | NA | drugbank , DGIDB | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.46 | approved | agonist |
| loperamide | mu-type opioid receptor | small molecule | NA | drugbank , DGIDB | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.46 | approved | agonist |
| loperamide | pro-opiomelanocortin | small molecule | NA | drugbank | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | approved | modulator |
| loperamide | pro-opiomelanocortin | small molecule | NA | drugbank | Inflammatory Bowel Diseases[MeSHID:D015212] Diarrhea[MeSHID:D003967] Patient Discharge[MeSHID:D010351] Gastroenteritis[MeSHID:D005759] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | modulator |
| click here to return to the previous page | ||||||||